Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
130.1 USD | -0.82% | +2.51% | +19.35% |
Apr. 29 | Merck Reports Positive Data for Investigational 21-Valent Pneumococcal Vaccine | MT |
Apr. 29 | Blackstone beats Concord with $1.6 bln bid for Hipgnosis Songs | RE |
MarketScreener Strategies
Merck and Company : Leader in oncology, modest valuation | October 29, 2019 at 11:04 am EDT |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- MarketScreener Strategies